Skip to content

Efficacy of amoxicillin/clavulanic acid after surgical drainage of perianal abscess in the prevention of the development of anal fistula. A randomized, double-blind clinical trial.

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520193-35-00
Acronym
PERIQxA
Enrollment
300
Registered
2025-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent surgery for their first episode of a perianal abscess.

Brief summary

Percentage of patients who develop perianal fistula.

Detailed description

Time to onset of fistula (months)., Complexity of the fistula according to the St James´s classification., Presence of new episode of perianal abscess at follow-up., Need for scheduled surgery for perianal fistula treatment (number of interventions, time since initial event and technique used)., Quality of life questionnaire after the onset of perianal fistula (QoLAF-Q questionnaire).

Interventions

DRUGAmoxicilina/Ácido clavulánico Viatris 875 mg/125 mg comprimidos recubiertos con película EFG

Sponsors

MARIANO ARTES CASELLES
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Percentage of patients who develop perianal fistula.

Secondary

MeasureTime frame
Time to onset of fistula (months)., Complexity of the fistula according to the St James´s classification., Presence of new episode of perianal abscess at follow-up., Need for scheduled surgery for perianal fistula treatment (number of interventions, time since initial event and technique used)., Quality of life questionnaire after the onset of perianal fistula (QoLAF-Q questionnaire).

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 2, 2026